A Study Of Mircera In Patients With Kidney Disease Who Are Not On Dialysis

Renal Tubular Acidosis, Distal, With Hemolytic Anemia Clinical Trial

Official title: Mircera In Patients With CKD Stages III-IV Not On Dialysis: Observational, Non-interventional Cohort Study

Status Completed

Clinical Trial Summary

This open-label, non-randomized, retrospective-prospective, non-interventional study will evaluate the efficacy and safety of Mircera in patients with stage III-IV chronic kidney disease (CKD) not on dialysis. Patients will receive open-label treatment with Mircera for 12 months at a dose to be determined by the investigator.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort

Related Conditions & MeSH terms

• Acidosis, Renal Tubular
• Anemia, Hemolytic
• Renal Tubular Acidosis, Distal, With Hemolytic Anemia

• NCT number: NCT02490514
• Study type: Observational
• Source: Hoffmann-La Roche
• Status: Completed
• Phase: N/A
• Start date: December 2009
• Completion date: February 2012